stocksQLINE
569.00-3.5 (-0.60%)
22 Oct, 12:00 AM

Annual Reports and Financial Documents

Q-Line Biotech Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2026
Annual Reports—
Quarterly Results—
Conference Calls
Presentations—

Corporate Announcements and Regulatory Filings

Q-Line Biotech Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under SEBI (Depositories and Participants) Regulations, 20188 Oct 2026
    Q-Line Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
  2. Shareholders meeting1 Oct 2026
    Q-Line Biotech Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 30, 2026 and Scrutinizer Report
  3. Shareholders meeting1 Oct 2026
    Q-Line Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026
  4. Shareholders meeting30 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
  5. Trading Window28 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  6. Updates11 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding 'The dispatch of the Notice of the Annual General Meeting scheduled to be held on September 30, 2026, to the shareholders whose registered email addresses could not be delivered due to email bounce-back, in accordance with Regulation 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.
  7. Updates8 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding 'Corrigendum to the Intimations dated 07.09.2026 Correction in the Number of the Annual General Meeting and Notice of Annual General Meeting as mentioned in the subject of the intimations'.
  8. Copy of Newspaper Publication8 Sept 2026
    Q-Line Biotech Limited has informed the Exchange about Copy of Newspaper Publication
  9. Updates7 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding 'Q-Line Biotech Limited has informed the Exchange about the Annual Report_2025-26 along with Notice of 37th Annual General Meeting along with and other information/communication to Shareholders, pursuant to Regulation 30, 34 and 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.'.
  10. General Updates7 Sept 2026
    Q-Line Biotech Limited has informed the Exchange about the Annual Report_2025-26 along with Notice of 37th Annual General Meeting along with and other information/communication to Shareholders, pursuant to Regulation 30, 34 and 36 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  11. Shareholders meeting7 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
  12. Outcome of Board Meeting5 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.
  13. Press Release2 Sept 2026
    Q-Line Biotech Limited has informed the Exchange regarding a press release dated September 02, 2026, titled Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Amended and Restated License Agreement with Boule Medical AB, Sweden.
  14. Credit Rating- New22 Aug 2026
    Q-Line Biotech Limited has informed the Exchange about Credit Rating- New
  15. Certificate under SEBI (Depositories and Participants) Regulations, 201827 Jul 2026
    Q-Line Biotech Limited has informed the Exchange about Reconciliation of share capital audit report as per Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018
  16. Certificate under SEBI (Depositories and Participants) Regulations, 201827 Jul 2026
    Q-Line Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018
  17. Analysts/Institutional Investor Meet/Con. Call Updates20 Jul 2026
    Q-Line Biotech Limited has informed the Exchange about Schedule of meeting to be held on 24th July 2026
  18. Reply to Clarification- Financial results2 Jul 2026
    The Exchange had sought clarification from Q-Line Biotech Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
  19. Analysts/Institutional Investor Meet/Con. Call Updates30 Jun 2026
    Q-Line Biotech Limited has informed the Exchange about Transcript of Earning call meeting held on 23rd June 2026
  20. Analysts/Institutional Investor Meet/Con. Call Updates30 Jun 2026
    Q-Line Biotech Limited has informed the Exchange about Schedule of meet proposed to be held on 03rd July 2026 at 03:30 PM

Frequently Asked Questions

Where can I download the annual report of Q-Line Biotech Ltd.?
Annual reports of Q-Line Biotech Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Q-Line Biotech Ltd.?
Quarterly earnings results and presentations of Q-Line Biotech Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Q-Line Biotech Ltd. publish earnings call transcripts?
Earnings call transcripts of Q-Line Biotech Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Q-Line Biotech Ltd.?
Investor presentations and annual day presentations of Q-Line Biotech Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Q-Line Biotech Ltd.?
Corporate announcements and regulatory filings of Q-Line Biotech Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Q-Line Biotech Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Q-Line Biotech Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Q-Line Biotech Ltd.?
The ISIN (International Securities Identification Number) of Q-Line Biotech Ltd. is INE1G2W01011. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Q-Line Biotech Ltd. listed?
Q-Line Biotech Ltd. is listed on NSE and BSE. The NSE symbol is QLINE and the BSE code is -.
Where can I find the shareholding pattern of Q-Line Biotech Ltd.?
The quarterly shareholding pattern of Q-Line Biotech Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Q-Line Biotech Ltd. on Sharpely?
Share price data for Q-Line Biotech Ltd. is updated as of 22 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.